[1] Quesnelle KM, Bystrom PV, Toledo-Pereyra LH. Molecular responses to ischemia and reperfusion in the liver. Arch Toxicol,2015,89:651-657.
[2] Dar WA, Sullivan E, Bynon JS, et al. Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms. Liver Int,2019,39:788-801.
[3] Hirao H, Nakamura K, Kupiec-Weglinski JW. Liver ischaemia-reperfusion injury: a new understanding of the role of innate immunity. Nat Rev Gastroenterol Hepatol 2021.
[4] Long H, Liao W, Wang L, et al. A Player and Coordinator: The Versatile Roles of Eosinophils in the Immune System. Transfus Med Hemother,2016,43:96-108.
[5] Frigerio S, da Costa V, Costa M, et al. Eosinophils Control Liver Damage by Modulating Immune Responses Against Fasciola hepatica. Front immunol,2020,11:579801.
[6] Goh YP, Henderson NC, Heredia JE, et al. Eosinophils secrete IL-4 to facilitate liver regeneration. Proc Natl Acad Sci U S A,2013,110:9914-9919.
[7] Seki T, Kumagai T, Kwansa-Bentum B, et al. Interleukin-4 (IL-4) and IL-13 suppress excessive neutrophil infiltration and hepatocyte damage during acute murine schistosomiasis japonica. Infect Immun,2012,80:159-168.
[8] Nissim Ben Efraim AH, Levi-Schaffer F. Roles of eosinophils in the modulation of angiogenesis. Chem Immunol Allergy,2014,99:138-154.
[9] Yamada T, Tani Y, Nakanishi H, et al. Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice. Faseb J, 2011,25:561-568.
[10] Shamri R, Xenakis JJ, Spencer LA. Eosinophils in innate immunity: an evolving story. Cell Tissue Res,2011,343:57-83.
[11] Lee JJ, Jacobsen EA, McGarry MP, et al. Eosinophils in health and disease: the LIAR hypothesis. Clin Exp Allergy,2010,40:563-575.
[12] Heredia JE, Mukundan L, Chen FM, et al. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell,2013,153:376-388.
[13] Masterson JC, McNamee EN, Fillon SA, et al. Eosinophil-mediated signalling attenuates inflammatory responses in experimental colitis. Gut,2015,64:1236-1247.
[14] Peiseler M, Tacke F. An Unexpected Line of Defense: Hepatoprotective Eosinophils in Ischemia-Reperfusion Injury. Hepatology,2021,74:2888-2890.
[15] Kleiner DE, Chalasani NP, Lee WM, et al. Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. Hepatology, 2014,59:661-670.
[16] Wang Y, Yang Y, Wang M, et al. Eosinophils attenuate hepatic ischemia-reperfusion injury in mice through ST2-dependent IL-13 production. Sci Transl Med,2021,13.
[17] Zuo Z, Wang C, Carpenter D, et al. Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection. Transplantation,2001,71:686-691.
[18] Arpaia N, Green JA, Moltedo B, et al. A Distinct Function of Regulatory T Cells in Tissue Protection. Cell,2015,162:1078-1089.
[19] Egholm C, Heeb LEM, Impellizzieri D, et al. The Regulatory Effects of Interleukin-4 Receptor Signaling on Neutrophils in Type 2 Immune Responses. Front Immunol,2019,10:2507.
[20] Peiseler M, Kubes P. More friend than foe: the emerging role of neutrophils in tissue repair. J Clin Invest,2019,129:2629-2639. |
